Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06278610 | Pelvic Exenteration and Laterally Extended Pelvic Resection(Pre-PEX) | unknown | — | 85 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06422546 | A Prospective, Multicenter, Non-interventional, Real-world Study to Characterize Changes in Molecular Markers After Three Weeks of Targeted Therapy With Oxitinib in EGFRm NSCLC(pre-FLAME) | unknown | — | 950 | Beijing Cancer Prevention & Treatment Society |
| 1 |
| May 21, 2024 |
| clinicaltrials |
| NCT06423066 | Developing a Machine Learning Model to Predict Pleural Adhesion Preoperatively Using Pleural Ultrasound | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT06423144 | PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7 | unknown | — | 150 | Shanghai Zhongshan HospitalOTHER | 0 | May 21, 2024 | clinicaltrials |
| NCT06423924 | Second Primary Cancer and Early-onset Colorectal Cancer | unknown | — | 10,000 | LI XIN-XIANGOTHER | 0 | May 21, 2024 | clinicaltrials |
| NCT06419114 | Exploration of Optical Coherence Tomography-Guided Transbronchial Biopsy in Peripheral Pulmonary Lesions(OCTGTBIPPL) | unknown | — | 150 | Sichuan Provincial People's HospitalOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT06421571 | The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients(GR-CTCL_CL) | unknown | — | 40 | National and Kapodistrian University of AthensOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT06421610 | OPC5: Pressurized IntraThoracic Aerosol Chemotherapy (PITAC) in Patients With Malignant Pleural Effusion. | unknown | Phase 1 | 20 | Odense University HospitalOTHER | 1 | May 20, 2024 | clinicaltrials |
| NCT06422156 | SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer(Nim-PC-28) | unknown | Phase 2 | 73 | Peking University Third HospitalOTHER | 0 | May 20, 2024 | clinicaltrials |
| NCT03337087 | Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer | unknown | Phase 1 / Phase 2 | 18 | Academic and Community Cancer Research UnitedOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04444869 | Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer(ENID) | unknown | Phase 2 | 28 | University of Missouri-ColumbiaOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04480502 | ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma(ENVASARC) | unknown | Phase 2 | 207 | Tracon Pharmaceuticals Inc.INDUSTRY | 2 | May 17, 2024 | clinicaltrials |
| NCT04909073 | Observational Study of Afatinib 30 mg Daily | unknown | — | 69 | National University Hospital, SingaporeOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04965129 | Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet | unknown | N/A | 50 | Universidade Federal do Rio de JaneiroOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT05065346 | Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC | unknown | N/A | 79 | Alpha Tau Medical LTD.INDUSTRY | 1 | May 17, 2024 | clinicaltrials |
| NCT05189197 | A Study to Evaluate Efficacy and Safety of Zanubrutinib With R-CHOP in Newly Diagnosed Non-GCB DLBCL Patients With Double Expression | unknown | Phase 2 | 41 | Fudan UniversityOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT05564858 | A Study of FDA022-BB05 in Subjects With Advanced Solid Malignant Tumors | unknown | Phase 1 | 107 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.INDUSTRY | 1 | May 17, 2024 | clinicaltrials |
| NCT06261008 | Interactive Telehealth Intervention to Increase Longitudinal Adherence to Repeat Faecal Immunochemical Test Screening | unknown | N/A | 370 | Chinese University of Hong KongOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06410716 | Comparing Valve-regulated Pleural Drainage to Traditional Closed Chest Tube Drainage | unknown | N/A | 100 | Peking Union Medical College HospitalOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06411457 | SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer | unknown | Phase 2 | 20 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06419140 | Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy | unknown | Phase 2 | 138 | Zhejiang Cancer HospitalOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT06419244 | Myosteatosis in Oeso-gastric Cancer: Clinical Impacts | unknown | N/A | 50 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT04071964 | Gut Microbiota, Anastomotic Leak and Colorectal Cancer | unknown | — | 300 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT04672005 | Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer | unknown | Phase 2 | 30 | Lyudmyla BerimOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05024318 | NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma(NAPSTER) | unknown | Phase 2 | 20 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05233787 | Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer (GRECCAR17)(GRECCAR17) | unknown | N/A | 212 | University Hospital, BordeauxOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05863013 | Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer | unknown | N/A | 80 | Centro Universitário Augusto MottaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05934864 | Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST) | unknown | — | 1,000 | Ruijin HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06036563 | Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing | unknown | — | 3,200 | Air Force Military Medical University, ChinaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06246630 | In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor | unknown | N/A | 20 | Ruijin HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06410625 | Evaluation of Response by FLT PET in Mesothelioma(FLT-MM) | unknown | N/A | 25 | Ankara UniversityOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06415162 | Evaluation of the Effects of Using Cooling Pillowcases, on the Symptoms of Hot Flushes, Sleep and Life Quality | unknown | N/A | 64 | Saglik Bilimleri UniversitesiOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06415708 | Obinutuzumab Combined With Bendamustine in the Treatment of Mature B-cell Lymphoma | unknown | Phase 2 | 134 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06415851 | Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab | unknown | Phase 2 | 36 | Zhangfa SongOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06416319 | Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct)(PreAct) | unknown | N/A | 164 | Universitätsmedizin MannheimOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06416501 | The Impact of Colorectal Cancer Screening on Surgical Outcomes | unknown | — | 4,000 | Fudan UniversityOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06417372 | Intraoperative Fluorescent Staining Combined With Microsurgery for Gliomas | unknown | — | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | May 16, 2024 | clinicaltrials |
| NCT06417658 | Comparing Cosmetic Outcomes: Endoscopic vs. Conventional Craniotomy for Frontal Skull Base Lesions | unknown | N/A | 42 | University of Health Sciences LahoreOTHER | 0 | May 16, 2024 | clinicaltrials |
| NCT02613988 | Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas | unknown | N/A | 100 | Asan Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT03141671 | Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) | unknown | Phase 2 | 345 | Dana-Farber Cancer InstituteOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT03188172 | MUK Nine b: OPTIMUM Treatment Protocol(MUKnineb) | unknown | Phase 2 | 95 | University of LeedsOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05075356 | iToBoS: Clinical Data Acquisition Study(iToBoS) | unknown | N/A | 600 | The University of QueenslandOTHER | 0 | May 14, 2024 | clinicaltrials |
| NCT05241106 | A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) | unknown | Phase 2 | 15 | Tarapeutics Science Inc.INDUSTRY | 1 | May 14, 2024 | clinicaltrials |
| NCT05396118 | Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients | unknown | Phase 2 | 15 | Rigshospitalet, DenmarkOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05412680 | Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)(TOETVA) | unknown | N/A | 60 | Fábio de Aquino CapelliOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05599698 | Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer | unknown | N/A | 38 | Bnai Zion Medical CenterOTHER_GOV | 1 | May 14, 2024 | clinicaltrials |
| NCT05650580 | TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors | unknown | Phase 1 | 26 | Tarapeutics Science Inc.INDUSTRY | 1 | May 14, 2024 | clinicaltrials |
| NCT05751356 | TR128 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 50 | Tarapeutics Science Inc.INDUSTRY | 1 | May 14, 2024 | clinicaltrials |
| NCT05868928 | Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis | unknown | — | 132 | Asan Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05929690 | Feasibility Trial Self-Acupuncture for Chemotherapy Cancer Patients(SACC) | unknown | N/A | 80 | University College London HospitalsOTHER | 1 | May 14, 2024 | clinicaltrials |
Data updated 24 days agoSource updated May 21, 2024source: clinicaltrials